TGF-β signaling is activated in patients with chronic HBV infection and repressed by SMAD7 overexpression after successful antiviral treatment.

Argentou N, Germanidis G, Hytiroglou P, Apostolou E, Vassiliadis T, Patsiaoura K, Sideras P, Germenis AE, Speletas M.

Inflamm Res. 2016 May;65(5):355-65. doi: 10.1007/s00011-016-0921-6. Epub 2016 Feb 9.

Για να δείτε το άρθρο πιέστε εδώ